Back to Browse Journals » International Journal of Nanomedicine » Volume 7
Corrigendum
Authors Hao Z, Zheng L, Kluwe L, Huang W
Received 16 March 2012
Accepted for publication 16 March 2012
Published 3 May 2012 Volume 2012:7 Pages 2209—2210
Hao Z, Zheng L, Kluwe L, Huang W. Ferritin light chain and squamous cell carcinoma antigen 1 are coreceptors for cellular attachment and entry of hepatitis B virus. Int J Nanomedicine. 2012;7:827–834.
1. The third affiliation, for Weida Huang, was incorrectly given as:
3Laboratory for Synthetic Biology, Centers for Nano-Medicine, Shanghai, People’s Republic of China.
The correct affiliation is as follows:
3Laboratory for Synthetic Biology, Centers for Nano-Medicine, Shanghai Advanced Research Institute, Chinese Academy of Sciences, Shanghai, People’s Republic of China.
2. Figures 1 and 2 have been corrected.
Read the original article
This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License.
By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.
Other article by this author:
Ferritin light chain and squamous cell carcinoma antigen 1 are coreceptors for cellular attachment and entry of hepatitis B virus
Hao ZJ, Zheng L, Kluwe L, Huang WD
International Journal of Nanomedicine 2012, 7:827-834
Published Date: 16 February 2012
Readers of this article also read:
Monitoring cancer stem cells: insights into clinical oncology
Lin SC, Xu YC, Gan ZH, Han K, Hu HY, Yao Y, Huang MZ, Min DL
OncoTargets and Therapy 2016, 9:731-740
Published Date: 11 February 2016
Companion diagnostics and molecular imaging-enhanced approaches for oncology clinical trials
Van Heertum RL, Scarimbolo R, Ford R, Berdougo E, O’Neal M
Drug Design, Development and Therapy 2015, 9:5215-5223
Published Date: 11 September 2015
Evolution of health technology assessment: best practices of the pan-Canadian Oncology Drug Review
Rocchi A, Chabot I, Glennie J
ClinicoEconomics and Outcomes Research 2015, 7:287-298
Published Date: 3 June 2015
Tracking the 2015 Gastrointestinal Cancers Symposium: bridging cancer biology to clinical gastrointestinal oncology
Aprile G, Leone F, Giampieri R, Casagrande M, Marino D, Faloppi L, Cascinu S, Fasola G, Scartozzi M
OncoTargets and Therapy 2015, 8:1149-1156
Published Date: 22 May 2015
Clinical utilities of aromatase inhibitors in breast cancer
Chumsri S
International Journal of Women's Health 2015, 7:493-499
Published Date: 6 May 2015
Brachytherapy in the treatment of cervical cancer: a review
Banerjee R, Kamrava M
International Journal of Women's Health 2014, 6:555-564
Published Date: 28 May 2014
Toll-like receptor 8: augmentation of innate immunity in platinum resistant ovarian carcinoma
Brueseke TJ, Tewari KS
Clinical Pharmacology: Advances and Applications 2013, 5:13-19
Published Date: 23 May 2013
Palliative care for adolescents and young adults with cancer
Rosenberg AR, Wolfe J
Clinical Oncology in Adolescents and Young Adults 2013, 3:41-48
Published Date: 24 March 2013
Palliative nursing care for children and adolescents with cancer
Foster TL, Bell CJ, McDonald CF, Harris JS, Gilmer MJ
Nursing: Research and Reviews 2012, 2:17-25
Published Date: 15 June 2012
Multidisciplinary care in pediatric oncology
Cantrell MA, Ruble K
Journal of Multidisciplinary Healthcare 2011, 4:171-181
Published Date: 30 May 2011
